跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dozypress-T - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dozypress-T
Approved
STANDARD
Dozypress-T
Remington Pharmaceutical Industries (Pvt.) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cc11345e2f97bf3a
Company
Remington Pharmaceutical Industries (Pvt.) Ltd.
Type
Standard
Approval Details
Approval Id
cc11345e2f97bf3a
Drug Approval Philippines Name
Dozypress-T
Product Name
Dozypress-T
Registration Number
DRP-12254
Brand Name
Dozypress-T
Generic Name
Dorzolamide (as hydrochloride) + Timolol (as maleate)
Dosage Form
Sterile Ophthalmic Solution (Eye Drops)
Dosage Strength
20mg/5mg per mL (2%/0.5% w/v)
Manufacturer
Remington Pharmaceutical Industries (Pvt.) Ltd.
Importer
Ophthamed Pharma Corp.
Distributor
Ophthamed Pharma Corp.
Issuance Date
25 August 2024
Expiry Date
07 February 2030
Pharmacologic Category
Carbonic Anhydrase Inhibitor/Beta Blocking Agent
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cc11345e2f97bf3a
Type
Standard
Back to Philippines FDA Approvals